BACKGROUND
veterinary medicines are concerned with the prevention, control, diagnosis, and treatment of diseases that affect the health of companion, domestic, exotic, wildlife, and production animals.
they are also used to improve feed efficiency, promote growth of livestock, and prevent the transmission of animal diseases to people.
the veterinary medicine industry in korea has grown following the expansion of livestock industry, and reached a market size of  <dig> millions usd by  <dig>  as of  <dig>  the total number of domestic manufacturers and importers of livestock are  <dig>  consisting of  <dig> manufacturers,  <dig> importers, and  <dig> repair shops of medical devices, while the number of approved products reached a total of  <dig> .
in korea, national product quality control measures for veterinary medicine consists of pre-market government testing system  and the national post-market surveillance  assessment on veterinary medicine before and after the distribution.
quality controls of antibiotics and biologics are performed by pmgts prior to reach the products in open market, ensuring that stringent efficacy and safety requirements are met in accordance with the “handling rules of veterinary medicinal products”  <cit> .
meanwhile, local manufacturing facilities and veterinary medicinal products quality have improved owing to the implementation of korea veterinary good manufacturing practice  on 1988–05- <dig> in accordance with the “kvgmp requirement for quality control” resulting in the gradual decrease of the government testing rejection rate  <cit> .
accordingly, testing of antibiotics by pmgts was abolished from  <dig> to 11- <dig>  while some biologics received partial exemptions from pmgts as of 2005–04- <dig>  the latter exemptions are limited to kvgmp-designated manufacturers.
for biologics, pmgts is performed on newly approved products, which become exempt from government testing after  <dig> or more consecutive lots are found to be acceptable.
following acquisition of exempt status, these products are still subject to spot-check government testing when necessary.
moreover, in the case of new antibiotics, the first  <dig> manufactured lots are designated as priority collection items and collected for testing  <cit> .
in the case of veterinary medicines currently in distribution, the active ingredient quantities of more than  <dig> medicines are tested each year in accordance with “tips for inspecting a veterinary pharmaceutical affair”  <cit> .
the korean ministry of agriculture, food, and rural affairs  has established collection and testing plans designating the number of products, types of active ingredients, and locations from which sampling should take place .
the korea animal and plant quarantine agency  and each individual city/province collects antibiotics, biologics and ocd currently in distribution from manufacturers, importers, and wholesalers of veterinary medicine, veterinary pharmacies, and veterinary hospitals in accordance with these testing plans.
during this process, products are collected, with priority given to products with questionable quality, products with sale prices below the cost of production which disrupt the distribution order, identical products sold at widely disparate prices, and products with high market share.
post-marketing quality control measures are implemented on these products through qia testing and levying of administrative measures such as suspension of marketing authorization and withdrawal of marketing authorization  <cit> .
the present study was performed to analyse the results of these veterinary medicine collections and tests over the past 10 years, between  <dig> and  <dig>  for the purpose of establishing baseline data for future veterinary medicine quality control measures.fig.
<dig> schematic figure showing pharmaceutical inspection of veterinary medicines by post-market surveillance assessment.
mafra: ministry of agriculture, food and rural affairs; qia: animal and plant quarantine agency
methods
test sample collection
the tested samples consisted of veterinary medicines stored or distributed by manufacturers, importers, and wholesalers of veterinary medicine, veterinary pharmacies, and veterinary hospitals, and were collected by qia and local municipalities throughout korea .
in total,  <dig>  products were collected and tested from  <dig> to  <dig>  all the drug samples were analysed three times immediately after collecting them, and the results were documented.
chemicals and reagents
reference standards were purchased from sigma-aldrich  for all the veterinary drugs.
all solvents used in chromatographic analysis were of hplc grade and were purchased from honeywell burdick & jackson .
de-ionized water was purified using a milli-q system .
solvents and reagents used in titrimetric assays were reagent grade and were obtained from duksan pure chemical co., ltd.  and honeywell burdick & jackson .
test methods
collected veterinary medicine samples were tested by the qia using various certified methods such as the korean standards of veterinary pharmaceuticals  <cit> , the korean pharmacopoeia  <cit> , the standards of national certification assay of the veterinary biological products  <cit>  and other foreign test methods which are summarized in “compendial analysis method for veterinary medicines, animal and plant quarantine agency , south korea” .
high performance liquid chromatography  and microbial assays were used for antibiotics while hplc, ph, and titration methods were used for other chemical agents.
finally, vaccines, classified as biologics, were tested using microbial and viral assays.table  <dig> outlines of analysis veterinary medicines
ocd other chemical drugs except antibiotics
RESULTS
national post-market surveillance assessment results by year
testing results for the veterinary medicine samples collected throughout korea between  <dig> and  <dig> are shown in table  <dig>  a total of  <dig>  samples, comprising  <dig> antibiotics,  <dig> ocd, and  <dig> biologics, were tested, among which a total of  <dig> samples were found to be noncompliant .
the number of noncompliant samples found in different drug groups are antibiotics  <dig> , ocd  <dig> , and biologics  <dig> .
the average noncompliance rate by year steadily decreased over the 10 years period, dropping below  <dig> % in  <dig> and reaching  <dig> % in  <dig> .table  <dig> results of national post-market surveillance assay in veterinary medicines from  <dig> to 2016
testedb
aother chemical drugs except antibiotics
bthe number of tested in the national post-market surveillance assay
cthe rate of non compliant products,  in the national post-market surveillance assay
fig.
<dig> violation rate of the post-market surveillance assay in veterinary medicines from  <dig> to  <dig>  ocd: other chemical drugs except antibiotics
reasons for noncompliance in collected and tested veterinary medicines
aother chemical drugs except antibiotics
bthe rate of noncompliance%
noncompliance rate by active ingredient in collected and tested veterinary medicines
seasonal effect on noncompliance in collected and tested veterinary medicines
an investigation of noncompliant veterinary medicines collected and tested between  <dig> and  <dig> showed that out of  <dig> total cases, the highest number of noncompliant cases  were found during the summer months .
during spring and fall , the number of noncompliant cases were  <dig> and  <dig>  respectively, while a relatively lower number of noncompliant cases  were found during winter  .fig.
<dig> seasonal effect on noncompliance in collected and tested veterinary medicines
discussion
veterinary medicines are essential for the advancement of the livestock industry, and the importance of quality control is emphasizing more due to the increase in the availability and demand of different types of veterinary medicines.
concentration of active ingredient is the most important characteristic of a drug product, as the amount of active ingredient allows to determine the intensities of treatment and toxicity of that particular drug.
moreover, the noncompliance rates of veterinary medicines are also pertaining in the elevation of contamination and drugs residues in the food products of animal origin  <cit> .
the npms assessment was initiated in  <dig> for the quality control of ocd which are in distribution.
antibiotics and biologics were previously assessed by both pmgts and npms.
the control of antibiotics was abolished from pmgts on 2000–11- <dig> and the exception biologics which pass ten times consecutively by pmgts have been incorporated into the npms assessment system on 2005–04- <dig>  <cit> .
so, npms is very important for the quality control of veterinary medicines as there is no other assessment system except npms.
testing methods have greatly improved from traditional bioassay examination owing to continued research and development.
improved hplc and titration methods are now being used for analysis based on the compendia as shown in table  <dig>  a small surveillance study in taiwan in the year of  <dig> accounted  <dig> noncompliant cases out of  <dig> cases , which is comparable with our study  <cit> .
the overall violation rate in korea in the year  <dig> was same as the violation rate in taiwan in  <dig>  as shown in fig.
<dig>  noncompliance rates by year showed an annual trend of gradual decrease from  <dig> % to  <dig> % which indicates that the implication of npms in veterinary medicine is helping to improve the quality of them.
in particular, antibiotics have shown very dramatic decrease in noncompliance rates , illustrating that veterinary medicine manufacturing facilities and quality control standards have significantly improved over time  <cit> .
that such annual trend reflects the effectiveness of the npms assessment and kvgmp programs.
meanwhile, no noncompliant cases for ocd were found in  <dig>  which was due to the testing of a large proportion of disinfectant samples  compared to the previous years.
the disinfectant reinforcement measure due to the  <dig> avian influenza outbreak was the behind cause to test many samples only for disinfectants.
vitamin a, which was often found as a noncompliant product in previous years, did not appear in the list of noncompliant products, as we have tested very few samples of vitamin a among the ocd in  <dig>
of the  <dig> noncompliant cases, “insufficiency of active ingredient quantity” was the reason for  <dig> cases, accounting for approximately  <dig> % of all noncompliant cases.
the next most frequently observed reason was “excess of active ingredient quantity,” with  <dig> cases observed .
in fact, manufacturing facilities cannot always give uniform products.
they should have the quality control system and need to check the quality-related parameters batch-wise to comply with the recommended specifications.
but, most of the manufacturers do not have quality control system and are unintentionally producing some products which contain less or excess amount of active ingredients.
these companies are not also accredited by kvgmp.
the second important cause of noncompliance is the using of low quality or potency of active ingredients in veterinary medicine by the manufacturers to reduce the production costs which is investigated by the audit of “veterinary management division” of qia.
so, this report is suggesting to the manufacturers to establish their own quality assurance facilities to produce quality products.
another cause of noncompliance is the storing of the products in improper storage condition particularly in summer season by the sellers and veterinary pharmacies .
it was also recorded in the previous years that the noncompliance rate was increased in summer season due to not maintaining the proper storage condition.
this indicates that the seasonal factors, including temperature-related issues during storage and distribution, may act as key factors of noncompliance.
thus, it is suggested to the sellers and distributors to maintain the veterinary medicine in proper storage condition as mention in guidelines.
as shown in table  <dig>  the noncompliance rate was high among antibiotics with higher molecular weight.
the antibiotics were also found to be noncompliant whose active ingredient contain for each dose are high such as tylosin and spiramycin.
among the nutritional supplements, noncompliance was the highest for fat soluble vitamins, such as vitamin a, which has low titre owing to being easily oxidized, as well as a few probiotics, whose cell count drops quickly when preservation conditions are not adequate.
currently, an average of 60– <dig> cases of biologics both subject to and exempt from national testing are assessed each year, and among these, noncompliance was reported for  <dig> cases of bovine rota-coronavirus live mixed vaccine, and  <dig> case each of newcastle live attenuated vaccine, canine parvo and coronavirus live mixed vaccines, porcine transmissible gastroenteritis rotavirus live mixed vaccine, porcine epidemic diarrhoea vaccine, and classic swine fever virus vaccine.
CONCLUSIONS
significant improvements in the manufacturing environment and quality control standards have been achieved through the implementation of kvgmp.
however, voluntary efforts by manufacturers are still needed to continue the application of kvgmp for the improvement of the quality of veterinary medicines.
in particular, ocd showed a high noncompliance rate of about 3%.
the ministry of agriculture, food and rural affairs  of korea is expecting to analyse the sales figures from the korea animal health products association, and the npms assay results from qia accordingly, to increase the statistical feasibility of the npms assessment results.
the mafra is also expecting to increase the number of test samples for ocd, as they present relatively high noncompliance rates.
it is also expected by mafra to reinforce testing during the vulnerable summer season.
proactive self-quality control by manufacturers for improved veterinary medicine quality must be promoted; while simultaneously, the efforts to establish an effective quality control system must continue as well.
abbreviations
hplchigh performance liquid chromatography.
kvgmpkorea veterinary good manufacturing practice
mafraministry of agriculture, food, and rural affairs
npmsnational post-market surveillance
ocdother chemical drugs except antibiotics
pmgtspre-market government testing system
qiaanimal and plant quarantine agency

 veterinary medicines are concerned with the prevention, control, diagnosis, and treatment of diseases that affect the health of companion, domestic, exotic, wildlife, and production animals. they are also used to improve feed efficiency, promote growth of livestock, and prevent the transmission of animal diseases to people. the veterinary medicine industry in korea has grown following the expansion of livestock industry, and reached a market size of millions usd by as of the total number of domestic manufacturers and importers of livestock are consisting of manufacturers, importers, and repair shops of medical devices, while the number of approved products reached a total of. in korea, national product quality control measures for veterinary medicine consists of pre-market government testing system and the national post-market surveillance assessment on veterinary medicine before and after the distribution. quality controls of antibiotics and biologics are performed by pmgts prior to reach the products in open market, ensuring that stringent efficacy and safety requirements are met in accordance with the “handling rules of veterinary medicinal products”. meanwhile, local manufacturing facilities and veterinary medicinal products quality have improved owing to the implementation of korea veterinary good manufacturing practice on 1988–05- in accordance with the “kvgmp requirement for quality control” resulting in the gradual decrease of the government testing rejection rate. accordingly, testing of antibiotics by pmgts was abolished from to 11- while some biologics received partial exemptions from pmgts as of 2005–04- the latter exemptions are limited to kvgmp-designated manufacturers. for biologics, pmgts is performed on newly approved products, which become exempt from government testing after or more consecutive lots are found to be acceptable. following acquisition of exempt status, these products are still subject to spot-check government testing when necessary. moreover, in the case of new antibiotics, the first manufactured lots are designated as priority collection items and collected for testing. in the case of veterinary medicines currently in distribution, the active ingredient quantities of more than medicines are tested each year in accordance with “tips for inspecting a veterinary pharmaceutical affair”. the korean ministry of agriculture, food, and rural affairs has established collection and testing plans designating the number of products, types of active ingredients, and locations from which sampling should take place. the korea animal and plant quarantine agency and each individual city/province collects antibiotics, biologics and ocd currently in distribution from manufacturers, importers, and wholesalers of veterinary medicine, veterinary pharmacies, and veterinary hospitals in accordance with these testing plans. during this process, products are collected, with priority given to products with questionable quality, products with sale prices below the cost of production which disrupt the distribution order, identical products sold at widely disparate prices, and products with high market share. post-marketing quality control measures are implemented on these products through qia testing and levying of administrative measures such as suspension of marketing authorization and withdrawal of marketing authorization. the present study was performed to analyse the results of these veterinary medicine collections and tests over the past 10 years, between and for the purpose of establishing baseline data for future veterinary medicine quality control measures.fig. schematic figure showing pharmaceutical inspection of veterinary medicines by post-market surveillance assessment. mafra: ministry of agriculture, food and rural affairs; qia: animal and plant quarantine agency methods test sample collection the tested samples consisted of veterinary medicines stored or distributed by manufacturers, importers, and wholesalers of veterinary medicine, veterinary pharmacies, and veterinary hospitals, and were collected by qia and local municipalities throughout korea. in total, products were collected and tested from to all the drug samples were analysed three times immediately after collecting them, and the results were documented. chemicals and reagents reference standards were purchased from sigma-aldrich for all the veterinary drugs. all solvents used in chromatographic analysis were of hplc grade and were purchased from honeywell burdick & jackson. de-ionized water was purified using a milli-q system. solvents and reagents used in titrimetric assays were reagent grade and were obtained from duksan pure chemical co., ltd. and honeywell burdick & jackson. test methods collected veterinary medicine samples were tested by the qia using various certified methods such as the korean standards of veterinary pharmaceuticals, the korean pharmacopoeia, the standards of national certification assay of the veterinary biological products and other foreign test methods which are summarized in “compendial analysis method for veterinary medicines, animal and plant quarantine agency, south korea”. high performance liquid chromatography and microbial assays were used for antibiotics while hplc, ph, and titration methods were used for other chemical agents. finally, vaccines, classified as biologics, were tested using microbial and viral assays.table outlines of analysis veterinary medicines ocd other chemical drugs except antibiotics  national post-market surveillance assessment results by year testing results for the veterinary medicine samples collected throughout korea between and are shown in table a total of samples, comprising antibiotics, ocd, and biologics, were tested, among which a total of samples were found to be noncompliant. the number of noncompliant samples found in different drug groups are antibiotics, ocd, and biologics. the average noncompliance rate by year steadily decreased over the 10 years period, dropping below % in and reaching % in.table results of national post-market surveillance assay in veterinary medicines from to 2016 testedb aother chemical drugs except antibiotics bthe number of tested in the national post-market surveillance assay cthe rate of non compliant products, in the national post-market surveillance assay fig. violation rate of the post-market surveillance assay in veterinary medicines from to ocd: other chemical drugs except antibiotics reasons for noncompliance in collected and tested veterinary medicines aother chemical drugs except antibiotics bthe rate of noncompliance% noncompliance rate by active ingredient in collected and tested veterinary medicines seasonal effect on noncompliance in collected and tested veterinary medicines an investigation of noncompliant veterinary medicines collected and tested between and showed that out of total cases, the highest number of noncompliant cases were found during the summer months. during spring and fall, the number of noncompliant cases were and respectively, while a relatively lower number of noncompliant cases were found during winter.fig. seasonal effect on noncompliance in collected and tested veterinary medicines discussion veterinary medicines are essential for the advancement of the livestock industry, and the importance of quality control is emphasizing more due to the increase in the availability and demand of different types of veterinary medicines. concentration of active ingredient is the most important characteristic of a drug product, as the amount of active ingredient allows to determine the intensities of treatment and toxicity of that particular drug. moreover, the noncompliance rates of veterinary medicines are also pertaining in the elevation of contamination and drugs residues in the food products of animal origin. the npms assessment was initiated in for the quality control of ocd which are in distribution. antibiotics and biologics were previously assessed by both pmgts and npms. the control of antibiotics was abolished from pmgts on 2000–11- and the exception biologics which pass ten times consecutively by pmgts have been incorporated into the npms assessment system on 2005–04-. so, npms is very important for the quality control of veterinary medicines as there is no other assessment system except npms. testing methods have greatly improved from traditional bioassay examination owing to continued research and development. improved hplc and titration methods are now being used for analysis based on the compendia as shown in table a small surveillance study in taiwan in the year of accounted noncompliant cases out of cases, which is comparable with our study. the overall violation rate in korea in the year was same as the violation rate in taiwan in as shown in fig. noncompliance rates by year showed an annual trend of gradual decrease from % to % which indicates that the implication of npms in veterinary medicine is helping to improve the quality of them. in particular, antibiotics have shown very dramatic decrease in noncompliance rates, illustrating that veterinary medicine manufacturing facilities and quality control standards have significantly improved over time. that such annual trend reflects the effectiveness of the npms assessment and kvgmp programs. meanwhile, no noncompliant cases for ocd were found in which was due to the testing of a large proportion of disinfectant samples compared to the previous years. the disinfectant reinforcement measure due to the avian influenza outbreak was the behind cause to test many samples only for disinfectants. vitamin a, which was often found as a noncompliant product in previous years, did not appear in the list of noncompliant products, as we have tested very few samples of vitamin a among the ocd in of the noncompliant cases, “insufficiency of active ingredient quantity” was the reason for cases, accounting for approximately % of all noncompliant cases. the next most frequently observed reason was “excess of active ingredient quantity,” with cases observed. in fact, manufacturing facilities cannot always give uniform products. they should have the quality control system and need to check the quality-related parameters batch-wise to comply with the recommended specifications. but, most of the manufacturers do not have quality control system and are unintentionally producing some products which contain less or excess amount of active ingredients. these companies are not also accredited by kvgmp. the second important cause of noncompliance is the using of low quality or potency of active ingredients in veterinary medicine by the manufacturers to reduce the production costs which is investigated by the audit of “veterinary management division” of qia. so, this report is suggesting to the manufacturers to establish their own quality assurance facilities to produce quality products. another cause of noncompliance is the storing of the products in improper storage condition particularly in summer season by the sellers and veterinary pharmacies. it was also recorded in the previous years that the noncompliance rate was increased in summer season due to not maintaining the proper storage condition. this indicates that the seasonal factors, including temperature-related issues during storage and distribution, may act as key factors of noncompliance. thus, it is suggested to the sellers and distributors to maintain the veterinary medicine in proper storage condition as mention in guidelines. as shown in table the noncompliance rate was high among antibiotics with higher molecular weight. the antibiotics were also found to be noncompliant whose active ingredient contain for each dose are high such as tylosin and spiramycin. among the nutritional supplements, noncompliance was the highest for fat soluble vitamins, such as vitamin a, which has low titre owing to being easily oxidized, as well as a few probiotics, whose cell count drops quickly when preservation conditions are not adequate. currently, an average of 60– cases of biologics both subject to and exempt from national testing are assessed each year, and among these, noncompliance was reported for cases of bovine rota-coronavirus live mixed vaccine, and case each of newcastle live attenuated vaccine, canine parvo and coronavirus live mixed vaccines, porcine transmissible gastroenteritis rotavirus live mixed vaccine, porcine epidemic diarrhoea vaccine, and classic swine fever virus vaccine.  significant improvements in the manufacturing environment and quality control standards have been achieved through the implementation of kvgmp. however, voluntary efforts by manufacturers are still needed to continue the application of kvgmp for the improvement of the quality of veterinary medicines. in particular, ocd showed a high noncompliance rate of about 3%. the ministry of agriculture, food and rural affairs of korea is expecting to analyse the sales figures from the korea animal health products association, and the npms assay results from qia accordingly, to increase the statistical feasibility of the npms assessment results. the mafra is also expecting to increase the number of test samples for ocd, as they present relatively high noncompliance rates. it is also expected by mafra to reinforce testing during the vulnerable summer season. proactive self-quality control by manufacturers for improved veterinary medicine quality must be promoted; while simultaneously, the efforts to establish an effective quality control system must continue as well. abbreviations hplchigh performance liquid chromatography. kvgmpkorea veterinary good manufacturing practice mafraministry of agriculture, food, and rural affairs npmsnational post-market surveillance ocdother chemical drugs except antibiotics pmgtspre-market government testing system qiaanimal and plant quarantine agency 
veterinary medicines have been widely used for the prevention and treatment of diseases, growth promotion, and to promote feeding efficacy in livestock. as the veterinary medicine industry has steadily grown, it is crucial to set up a baseline for the quality of medicine as well as the insufficiency or excessiveness of the active ingredients in drug products to ensure the compliance, safety and efficacy of these medicines. thus, the 10 years data of post-marketing quality control study was summarized to determine the rate and extent of non-compliance of these medicines and to establish baseline data for future quality control measures of veterinary medicine. the overall trend presented gradually decreasing violation rates, suggesting that the quality of veterinary medicines has improved. veterinary medicinequality controlpost-market surveillance assayanimal and plant quarantine agency101-6200-6240-301-210lee kwang-jick issue-copyright-statement© the author 2017 a total of cases were deemed noncompliant, with the average noncompliance rate for all medicine types being %. the average noncompliance rates for antibiotics, biologics and other chemical drugs except antibiotics were %, %, and %, respectively. in this study, drugs for veterinary use were collected per year from each city and province in korea and analysed for the quantity of active ingredients according to the “national post-market surveillance system” over the past decade. the first leading cause for noncompliant products was insufficient quantity of major ingredients, and the second leading cause was the existence of excess amount of active ingredients. the npms assessment was performed using liquid and gas chromatography, titration, uv/vis spectrophotometry, and bioassays. consistent application of the npms assessment and the establishment of the korea veterinary good manufacturing practice will help to maintain the good quality of medicine.
 veterinary medicines have been widely used for the prevention and treatment of diseases, growth promotion, and to promote feeding efficacy in livestock. as the veterinary medicine industry has steadily grown, it is crucial to set up a baseline for the quality of medicine as well as the insufficiency or excessiveness of the active ingredients in drug products to ensure the compliance, safety and efficacy of these medicines. thus, the 10 years data of post-marketing quality control study was summarized to determine the rate and extent of non-compliance of these medicines and to establish baseline data for future quality control measures of veterinary medicine.  in this study, drugs for veterinary use were collected per year from each city and province in korea and analysed for the quantity of active ingredients according to the “national post-market surveillance system” over the past decade. the npms assessment was performed using liquid and gas chromatography, titration, uv/vis spectrophotometry, and bioassays. a total of cases were deemed noncompliant, with the average noncompliance rate for all medicine types being %. the average noncompliance rates for antibiotics, biologics and other chemical drugs except antibiotics were %, %, and %, respectively. the first leading cause for noncompliant products was insufficient quantity of major ingredients, and the second leading cause was the existence of excess amount of active ingredients. tylosin, spiramycin, ampicillin, tetracyclines and penicillins were most frequently found to be noncompliant among antibiotics. among the ocd, the noncompliance was found commonly in vitamin a.  the overall trend presented gradually decreasing violation rates, suggesting that the quality of veterinary medicines has improved. consistent application of the npms assessment and the establishment of the korea veterinary good manufacturing practice will help to maintain the good quality of medicine. keywords veterinary medicinequality controlpost-market surveillance assayanimal and plant quarantine agency101-6200-6240-301-210lee kwang-jick issue-copyright-statement© the author 2017 